These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16682238)

  • 1. The impact of lesion length on angiographic restenosis after vertebral artery origin stenting.
    Lin YH; Liu YC; Tseng WY; Juang JM; Hung CS; Lin JW; Jeng JS; Yip PK; Kao HL
    Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):379-85. PubMed ID: 16682238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic ostial vertebral artery stenosis treated with tubular coronary stents: clinical results and restenosis analysis.
    Lin YH; Juang JM; Jeng JS; Yip PK; Kao HL
    J Endovasc Ther; 2004 Dec; 11(6):719-26. PubMed ID: 15615563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Risk of In-Stent Restenosis and Stent Fracture for Extracranial Vertebral Artery Stenting.
    Li MKA; Tsang ACO; Tsang FCP; Ho WS; Lee R; Leung GKK; Lui WM
    Clin Neuroradiol; 2019 Dec; 29(4):701-706. PubMed ID: 30039353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of vessel size and tortuosity on in-stent restenosis after stent implantation in the vertebral artery ostium.
    Zhou Z; Yin Q; Xu G; Yue X; Zhang R; Zhu W; Fan X; Ma M; Liu X
    Cardiovasc Intervent Radiol; 2011 Jun; 34(3):481-7. PubMed ID: 20683721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes and influencing factors of in-stent restenosis after stenting for symptomatic stenosis of the vertebral V1 segment.
    Che WQ; Dong H; Jiang XJ; Peng M; Zou YB; Xiong HL; Yang YJ; Gao RL
    J Vasc Surg; 2018 Nov; 68(5):1406-1413. PubMed ID: 29789215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial occlusions increase the risk of in-stent restenosis after vertebral artery ostium stenting.
    Li J; Hua Y; Needleman L; Forsberg F; Eisenbray JR; Li Z; Liu R; Tian X; Jiao L; Liu JB
    J Neurointerv Surg; 2019 Jun; 11(6):574-578. PubMed ID: 30337379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and Predictors of the In-stent Restenosis after Vertebral Artery Ostium Stenting.
    Chen W; Huang F; Li M; Jiang Y; He J; Li H; Dai Z; Shi W; Zhu M; Chen G; Yang F; Zhang R
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3030-3035. PubMed ID: 30093203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting stent for the treatment of symptomatic vertebral origin stenosis: Long-term results.
    Chen X; Huang Q; Hong B; Zhang Y; Xu Y; Liu J
    J Clin Neurosci; 2011 Jan; 18(1):47-51. PubMed ID: 20888236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with vertebral artery origin stenting and ostium dilatation: results of treatment and clinical outcomes.
    Rangel-Castilla L; Gandhi S; Munich SA; Cress MC; Sonig A; Krishna C; Hopkins LN; Snyder KV; Levy EI; Siddiqui AH
    J Neurointerv Surg; 2016 May; 8(5):476-80. PubMed ID: 25838198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and safety of transradial arterial approach for simultaneous right and left vertebral artery angiographic studies and stenting.
    Yip HK; Youssef AA; Chang WN; Lu CH; Yang CH; Chen SM; Wu CJ
    Cardiovasc Intervent Radiol; 2007; 30(5):840-6. PubMed ID: 17587084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restenosis rates following vertebral artery origin stenting: does stent type make a difference?
    Ogilvy CS; Yang X; Natarajan SK; Hauck EF; Sun L; Lewis-Mason L; Hopkins LN; Siddiqui AH; Levy EI
    J Invasive Cardiol; 2010 Mar; 22(3):119-24. PubMed ID: 20197579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease.
    Fiorella D; Chow MM; Anderson M; Woo H; Rasmussen PA; Masaryk TJ
    Neurosurgery; 2007 Aug; 61(2):236-42; discussion 242-3. PubMed ID: 17762735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stenting of vertebral artery origin atherosclerosis in high-risk patients: bare or coated? A single-center consecutive case series.
    Akins PT; Kerber CW; Pakbaz RS
    J Invasive Cardiol; 2008 Jan; 20(1):14-20. PubMed ID: 18174613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, risk, and treatment of binary restenosis after vertebral artery stenting.
    Qiu Z; Liu J; Huang R; Liu D; Dai Z; Luo M; Jiang Y
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):404-409. PubMed ID: 32277795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of self-expanding stents with distal embolic protection to balloon-expandable stents without a protection device in the treatment of symptomatic vertebral artery origin stenosis: a prospective randomized trial.
    Geng X; Hussain M; Du H; Zhao L; Chen J; Su W; Ma L; Gao Z; Ding Y; Ji X
    J Endovasc Ther; 2015 Jun; 22(3):436-44. PubMed ID: 25862360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent fracture in revascularization for symptomatic ostial vertebral artery stenosis.
    Tsutsumi M; Kazekawa K; Onizuka M; Kodama T; Matsubara S; Aikawa H; Iko M; Nii K; Etou H; Tanaka A
    Neuroradiology; 2007 Mar; 49(3):253-7. PubMed ID: 17151868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertebral artery origin stents revisited: improved results with paclitaxel-eluting stents.
    Park MS; Fiorella D; Stiefel MF; Dashti SR; Gonzalez LF; McDougall CG; Albuquerque FC
    Neurosurgery; 2010 Jul; 67(1):41-8; discussion 48. PubMed ID: 20568666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stenting of symptomatic vertebral artery ostium stenosis with self-expanding stents.
    Li Z; Zhang Y; Hong B; Deng B; Xu Y; Zhao W; Liu J; Huang Q
    J Clin Neurosci; 2014 Feb; 21(2):274-7. PubMed ID: 24128770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for in-stent restenosis after balloon-mounted stent placement for symptomatic intracranial atherosclerosis.
    Zhu SG; Zhang RL; Liu WH; Yin Q; Zhou ZM; Zhu WS; Zhu YL; Xu GL; Liu XF
    Eur J Vasc Endovasc Surg; 2010 Oct; 40(4):499-506. PubMed ID: 20554461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.